Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Biotech
  • Healthcare
  • Cleantech
  • Technology
  • Other

University

  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • IP Venture Fund II
  • Top 10 Holdings
    by value
Medical Equipment & Supplies

University: Leeds

Company Stage: Quoted

Website: http://www.avacta.com

Avacta Group Plc

Avacta is developing innovative chemical and biological detection technology for the healthcare, defence, biotechnology and pharmaceuticals sectors.

Avacta's market driven technology portfolio has applications in homeland security, clinical diagnostics and personalised medicine, high throughput screening and bioprocess measurement.

As at 31 Dec 2013

IP Group holding

IP Venture Fund* holding

27.6%

2.4%

*IP Group has a 10%
economic interest in IP
Venture Fund

Holdings represent undiluted beneficial equity interest excluding debt

Avacta

Related news

16 Oct 2014
30 Sep 2014

There is currently no news available.

More portfolio news